Biotech 2050 Podcast cover image

Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics

Biotech 2050 Podcast

CHAPTER

Adapting Preclinical and Clinical Programs in Ophthalmology During the Pandemic

This chapter explores the impact of the pandemic on preclinical and clinical programs in ophthalmology, including the complexities of starting human trials and the delays caused by the need for sophisticated equipment and in-person visits. The hosts discuss the challenges faced and the efficiencies gained from the experience.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner